Description: Guided Therapeutics, Inc. is the developer of the LuViva Advanced Cervical Scan, a rapid and painless test for the early detection of disease that leads to cervical cancer. LuViva is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. LuViva works by shining light on the cervical and reading the returned light with a spectrometer. LuViva looks for chemical and physical markers of precancer. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are known immediately. LuViva is approved for sale in Canada, Mexico, the European Union and several other countries around the world. For more information, visit www.guidedinc.com.
Home Page: www.guidedinc.com
5835 Peachtree Corners East
Peachtree Corners,
GA
30092
United States
Phone:
770 242 8723
Officers
Name | Title |
---|---|
Dr. Mark L. Faupel Ph.D. | CEO, President, COO, Acting CFO, Secretary & Director |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0 |
Price-to-Sales TTM: | 250.2918 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 4 |